Correlation Between Aerovate Therapeutics and Universal Media

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aerovate Therapeutics and Universal Media at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aerovate Therapeutics and Universal Media into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aerovate Therapeutics and Universal Media Group, you can compare the effects of market volatilities on Aerovate Therapeutics and Universal Media and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aerovate Therapeutics with a short position of Universal Media. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aerovate Therapeutics and Universal Media.

Diversification Opportunities for Aerovate Therapeutics and Universal Media

-0.72
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Aerovate and Universal is -0.72. Overlapping area represents the amount of risk that can be diversified away by holding Aerovate Therapeutics and Universal Media Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Universal Media Group and Aerovate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aerovate Therapeutics are associated (or correlated) with Universal Media. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Universal Media Group has no effect on the direction of Aerovate Therapeutics i.e., Aerovate Therapeutics and Universal Media go up and down completely randomly.

Pair Corralation between Aerovate Therapeutics and Universal Media

Given the investment horizon of 90 days Aerovate Therapeutics is expected to under-perform the Universal Media. But the stock apears to be less risky and, when comparing its historical volatility, Aerovate Therapeutics is 12.7 times less risky than Universal Media. The stock trades about -0.04 of its potential returns per unit of risk. The Universal Media Group is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  4.20  in Universal Media Group on September 13, 2024 and sell it today you would lose (1.20) from holding Universal Media Group or give up 28.57% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Aerovate Therapeutics  vs.  Universal Media Group

 Performance 
       Timeline  
Aerovate Therapeutics 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Aerovate Therapeutics are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of rather fragile basic indicators, Aerovate Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.
Universal Media Group 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Universal Media Group has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable technical and fundamental indicators, Universal Media is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Aerovate Therapeutics and Universal Media Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aerovate Therapeutics and Universal Media

The main advantage of trading using opposite Aerovate Therapeutics and Universal Media positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aerovate Therapeutics position performs unexpectedly, Universal Media can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Universal Media will offset losses from the drop in Universal Media's long position.
The idea behind Aerovate Therapeutics and Universal Media Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Other Complementary Tools

Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Stocks Directory
Find actively traded stocks across global markets
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing